PBRM1 and renal cell carcinoma: PBRM1, a target subunit of PBAF, is a common oncogene with a 40% mutation rate in renal cell carcinoma, and our previous study found that deletion of PBRM1 could activate the AKT pathway and glycolytic pathway and thus affect the function of ccRCC cells.31